These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 1687974

  • 21. Infection with human T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): Implications for blood transfusion safety.
    Murphy EL.
    Transfus Clin Biol; 2016 Feb; 23(1):13-9. PubMed ID: 26778839
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London.
    Brennan M, Runganga J, Barbara JA, Contreras M, Tedder RS, Garson JA, Tuke PW, Mortimer PP, McAlpine L, Tosswill JH.
    BMJ; 1993 Nov 13; 307(6914):1235-9. PubMed ID: 8281054
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Human T-lymphotropic virus infection: is it a threat?
    Zaaijer H.
    Transplant Proc; 1996 Oct 13; 28(5):2940. PubMed ID: 8908133
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
    Sertöz R, Turhan A, Bozkurt H, Samlıoğlu P, Değirmenci A, Aydınok Y, Erensoy S.
    Mikrobiyol Bul; 2010 Oct 13; 44(4):579-84. PubMed ID: 21063970
    [Abstract] [Full Text] [Related]

  • 29. Selectivity of human T lymphotropic virus type-1 (HTLV-1) and HTLV-2 infection among different populations in Brazil.
    Gabbai AA, Bordin JO, Vieira-Filho JP, Kuroda A, Oliveira AS, Cruz MV, Ribeiro AA, Delaney SR, Henrard DR, Rosario J.
    Am J Trop Med Hyg; 1993 Dec 13; 49(6):664-71. PubMed ID: 8279633
    [Abstract] [Full Text] [Related]

  • 30. Prevalence of antibodies to human T-lymphotropic virus types I and II in volunteer blood donors and high-risk groups in northwestern Greece.
    Dalekos GN, Zervou E, Karabini F, Elisaf M, Bourantas K, Siamopoulos KC.
    Transfusion; 1995 Jun 13; 35(6):503-6. PubMed ID: 7770902
    [Abstract] [Full Text] [Related]

  • 31. Blood safety strategies for human T-cell lymphotropic virus in Europe.
    Laperche S, Worms B, Pillonel J, European Network of Transfusion Medecine Societies, Steering Committee.
    Vox Sang; 2009 Feb 13; 96(2):104-10. PubMed ID: 19076337
    [Abstract] [Full Text] [Related]

  • 32. Transmission of human T-lymphotropic virus types I and II by blood transfusion. A retrospective study of recipients of blood components (1983 through 1988). The American Red Cross HTLV-I/II Collaborative Study Group.
    Sullivan MT, Williams AE, Fang CT, Grandinetti T, Poiesz BJ, Ehrlich GD.
    Arch Intern Med; 1991 Oct 13; 151(10):2043-8. PubMed ID: 1929693
    [Abstract] [Full Text] [Related]

  • 33. HTLV infection in ELISA-negative blood donors.
    Zehender G, Girotto M, De Maddalena C, Francisco G, Moroni M, Galli M.
    AIDS Res Hum Retroviruses; 1996 May 20; 12(8):737-40. PubMed ID: 8744584
    [Abstract] [Full Text] [Related]

  • 34. HTLV in the Americas.
    Proietti FA, Carneiro-Proietti AB.
    Rev Panam Salud Publica; 2006 Jan 20; 19(1):7-8. PubMed ID: 16536933
    [No Abstract] [Full Text] [Related]

  • 35. Human T-lymphotropic virus (HTLV) types I and II: seroprevalence among intravenous drug users in continental France. Retrovirus Study Group of the French Society of Blood Transfusion.
    Coste J, Lemaire JM, Couroucé AM, Canavaggio M.
    AIDS; 1993 Mar 20; 7(3):440-1. PubMed ID: 8097098
    [No Abstract] [Full Text] [Related]

  • 36. Simultaneous confirmation and differentiation of human T-lymphotropic virus types I and II infection by modified western blot containing recombinant envelope glycoproteins.
    Brodine SK, Kaime EM, Roberts C, Turnicky RP, Lal RB.
    Transfusion; 1993 Mar 20; 33(11):925-9. PubMed ID: 7903127
    [Abstract] [Full Text] [Related]

  • 37. Human T cell leukemia virus (HTLV-I/II) serodiagnostic testing: disparate results among a cohort of intravenous drug users.
    Aboulafia DM, Feigal E, Vranzian K, Bennett C, Blattner W, Moss A, Slamon D.
    AIDS Res Hum Retroviruses; 1993 Oct 20; 9(10):1043-50. PubMed ID: 7904169
    [Abstract] [Full Text] [Related]

  • 38. [HIV-2 and HTLV-1/2 infections in Spain].
    Treviño A, Soriano V, Grupo Español para el Estudio del VIH-2 y HTLV-1/2.
    Med Clin (Barc); 2010 Jun 12; 135(2):67-9. PubMed ID: 19560171
    [No Abstract] [Full Text] [Related]

  • 39. Human T-cell lymphotrophic virus in California's injection drug users.
    Trachtenberg AI, Gaudino JA, Hanson CV.
    J Psychoactive Drugs; 1991 Jun 12; 23(2):225-32. PubMed ID: 1765894
    [Abstract] [Full Text] [Related]

  • 40. Transfusion transmission of human T-lymphotropic virus types I and II: serologic and polymerase chain reaction results in recipients identified through look-back investigations.
    Kleinman S, Swanson P, Allain JP, Lee H.
    Transfusion; 1993 Jan 12; 33(1):14-8. PubMed ID: 8424263
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.